REFERENCES
- Curiel TJ, Coukos G, Zou L, Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942–929.
- Bates GJ, Fox SB, Han C, Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol. 2006;24:5373–5380.
- Sasada T, Kimura M, Yoshida Y, CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer. 2003;98:1089–1099.
- Yamamoto T, Yanagimoto H, Satoi S, Circulating CD4+CD25 +regulatory T cells in patients with pancreatic cancer. Pancreas. 2012;41:409–415.
- Gupta R, Ganeshan P, Hakim M, Significantly reduced regulatory T cell population in patients with untreated multiple myeloma. Leuk Res. 2011;35:874–878.
- Matthay KK, Villablanca JG, Seeger RC, Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999;341:1165–1173.
- Strauss L, Bergmann C, Szczepanski M, A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin Cancer Res. 2007;13(15 Pt 1):4345–4354.
- Mougiakakos D, Choudhury A, Lladser A, Regulatory T cells in cancer. Adv Cancer Res. 2010;107:57–117.
- Wolf AM, Wolf D, Steurer M, Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res. 2003;9:606–612.
- Gowda M, Godder K, Kmieciak M, Distinct signatures of the immune responses in low risk versus high risk neuroblastoma. J Transl Med. 2011;9:170.
- Apps JR, Hasan F, Campus O, The immune environment of paediatric solid malignancies: evidence from an immunohistochemical study of clinical cases. Fetal Pediatr Pathol. 2013;32:298–307.
- Asgharzadeh S, Salo JA, Ji L, Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. J Clin Oncol. 2012;30:3525–3532.
- French JD, Weber ZJ, Fretwell DL, Tumor-associated lymphocytes and increased FoxP3 +regulatory T cell frequency correlate with more aggressive papillary thyroid cancer. J Clin Endocrinol Metab. 2010;95:2325–2333.
- Le DT, Jaffee EM. Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective. Cancer Res. 2012;72:3439–3444.
- Beyer M, Classen S, Endl E, Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3. Clin Dev Immunol. 2011;2011:734036.